AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
DESIGN OF POLYMERS TO INCREASE THE EFFICIENCY OF ENDOSOMAL RELEASE OFDRUGS
Authors: SANTOS AF MURTHY N STAYTON PS PRESS OW TIRRELL D HOFFMAN AS
Citation: Af. Santos et al., DESIGN OF POLYMERS TO INCREASE THE EFFICIENCY OF ENDOSOMAL RELEASE OFDRUGS, Journal of investigative medicine, 46(1), 1998, pp. 91-91
PROSPECTS FOR THE MANAGEMENT OF NON-HODGKINS-LYMPHOMAS WITH MONOCLONAL-ANTIBODIES AND IMMUNOCONJUGATES
Authors: PRESS OW
Citation: Ow. Press, PROSPECTS FOR THE MANAGEMENT OF NON-HODGKINS-LYMPHOMAS WITH MONOCLONAL-ANTIBODIES AND IMMUNOCONJUGATES, The cancer journal from Scientific American, 4, 1998, pp. 19-26
NEWER TREATMENTS FOR NON-HODGKINS-LYMPHOMA - MONOCLONAL-ANTIBODIES
Authors: MALONEY DG PRESS OW
Citation: Dg. Maloney et Ow. Press, NEWER TREATMENTS FOR NON-HODGKINS-LYMPHOMA - MONOCLONAL-ANTIBODIES, Oncology, 12(10), 1998, pp. 63-76
PACLITAXEL FOR THE TREATMENT OF LYMPHOMA - IN REPLY
Authors: PRESS OW
Citation: Ow. Press, PACLITAXEL FOR THE TREATMENT OF LYMPHOMA - IN REPLY, Journal of clinical oncology, 16(6), 1998, pp. 2290-2290
PHASE-II TRIAL OF PACLITAXEL BY 24-HOUR CONTINUOUS-INFUSION FOR RELAPSED NON-HODGKINS-LYMPHOMAS - SOUTHWEST-ONCOLOGY-GROUP TRIAL-9246
Authors: PRESS OW LEBLANC M OROURKE TJ GAGNET S CHAPMAN RA BALCERZAK SP FISHER RI
Citation: Ow. Press et al., PHASE-II TRIAL OF PACLITAXEL BY 24-HOUR CONTINUOUS-INFUSION FOR RELAPSED NON-HODGKINS-LYMPHOMAS - SOUTHWEST-ONCOLOGY-GROUP TRIAL-9246, Journal of clinical oncology, 16(2), 1998, pp. 574-578
FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE
Authors: LIU SY EARY JF PETERSDORF SH MARTIN PJ MALONEY DG APPELBAUM FR MATTHEWS DC BUSH SA DURACK LD FISHER DR GOOLEY TA BERNSTEIN ID PRESS OW
Citation: Sy. Liu et al., FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE, Journal of clinical oncology, 16(10), 1998, pp. 3270-3278
TRAINING RESOURCE DOCUMENT FOR CURRICULUM-DEVELOPMENT IN MEDICAL ONCOLOGY
Authors: MORTIMER JE BAJORIN D BUCKNER J LEICHMAN CG MAYER R PRESS OW
Citation: Je. Mortimer et al., TRAINING RESOURCE DOCUMENT FOR CURRICULUM-DEVELOPMENT IN MEDICAL ONCOLOGY, Journal of clinical oncology, 16(1), 1998, pp. 372-379
MODIFICATION OF RICIN-A CHAIN, BY ADDITION OF ENDOPLASMIC-RETICULUM (KDEL) OR GOLGI (YQRL) RETENTION SEQUENCES, ENHANCES ITS CYTOTOXICITY AND TRANSLOCATION
Authors: ZHAN JB STAYTON P PRESS OW
Citation: Jb. Zhan et al., MODIFICATION OF RICIN-A CHAIN, BY ADDITION OF ENDOPLASMIC-RETICULUM (KDEL) OR GOLGI (YQRL) RETENTION SEQUENCES, ENHANCES ITS CYTOTOXICITY AND TRANSLOCATION, Cancer immunology and immunotherapy, 46(1), 1998, pp. 55-60
APOPTOSIS OF MALIGNANT HUMAN B-CELLS BY LIGATION OF CD20 WITH MONOCLONAL-ANTIBODIES
Authors: SHAN D LEDBETTER JA PRESS OW
Citation: D. Shan et al., APOPTOSIS OF MALIGNANT HUMAN B-CELLS BY LIGATION OF CD20 WITH MONOCLONAL-ANTIBODIES, Blood, 91(5), 1998, pp. 1644-1652
IMPORTANCE OF PRETREATMENT RADIATION ABSORBED DOSE ESTIMATION FOR RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA
Authors: EARY JF KROHN KA PRESS OW DURACK L BERNSTEIN ID
Citation: Jf. Eary et al., IMPORTANCE OF PRETREATMENT RADIATION ABSORBED DOSE ESTIMATION FOR RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA, Nuclear medicine and biology, 24(7), 1997, pp. 635-638
RADIOIMMUNOTHERAPY STRATEGIES FOR NON-HODGKINS-LYMPHOMAS
Authors: CORCORAN MC EARY J BERNSTEIN I PRESS OW
Citation: Mc. Corcoran et al., RADIOIMMUNOTHERAPY STRATEGIES FOR NON-HODGKINS-LYMPHOMAS, Annals of oncology, 8, 1997, pp. 133-138
THE POTENTIAL FOR IMMUNOCONJUGATES IN LYMPHOMA THERAPY
Authors: LIU SY PRESS OW
Citation: Sy. Liu et Ow. Press, THE POTENTIAL FOR IMMUNOCONJUGATES IN LYMPHOMA THERAPY, Hematology/oncology clinics of North America, 11(5), 1997, pp. 987
PHASE-I STUDY OF I-131 ANTI-CD45 ANTIBODY PLUS CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION FOR ADVANCED ACUTE-LEUKEMIA AND MYELODYSPLASTIC SYNDROME
Authors: MATTHEWS DC APPELBAUM FR EARY JF MITCHELL D PRESS OW BERNSTEIN ID
Citation: Dc. Matthews et al., PHASE-I STUDY OF I-131 ANTI-CD45 ANTIBODY PLUS CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION FOR ADVANCED ACUTE-LEUKEMIA AND MYELODYSPLASTIC SYNDROME, Blood, 90(10), 1997, pp. 1854-1854
HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS
Authors: BRUNVAND MW BENSINGER WI SOLL E WEAVER CH ROWLEY SD APPELBAUM FR LILLEBY K CLIFT RA GOOLEY TA PRESS OW FEFER A STORB R SANDERS JE MARTIN PL CHAUNCEY T MAZIARZ RT ZUCKERMAN N MONTGOMERY P DORN R WEIDEN PL DEMIRER T HOLMBERG LA SCHIFFMAN K MCSWEENEY PA MALONEY DG BUCKNER CD
Citation: Mw. Brunvand et al., HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS, Bone marrow transplantation, 18(1), 1996, pp. 131-141
RADIOIMMUNOTHERAPY TREATMENT PLANNING BASED ON RADIATION ABSORBED DOSE OR PATIENT SIZE
Authors: EARY JF KROHN KA PRESS OW FISHER D BERNSTEIN ID
Citation: Jf. Eary et al., RADIOIMMUNOTHERAPY TREATMENT PLANNING BASED ON RADIATION ABSORBED DOSE OR PATIENT SIZE, The Journal of nuclear medicine, 37(5), 1996, pp. 162-162
COMPARATIVE METABOLISM AND RETENTION OF I-125, Y-90, AND IN-111 RADIOIMMUNOCONJUGATES BY CANCER-CELLS
Authors: PRESS OW SHAN D HOWELLCLARK J EARY J APPELBAUM FR MATTHEWS D KING DJ HAINES AMR HAMANN P HINMAN L SHOCHAT D BERNSTEIN ID
Citation: Ow. Press et al., COMPARATIVE METABOLISM AND RETENTION OF I-125, Y-90, AND IN-111 RADIOIMMUNOCONJUGATES BY CANCER-CELLS, Cancer research, 56(9), 1996, pp. 2123-2129
ADVANCES IN IMMUNOTOXIN BIOLOGY AND THERAPY - A SUMMARY OF THE 4TH INTERNATIONAL-SYMPOSIUM ON IMMUNOTOXINS
Authors: FRANKEL AE FITZGERALD D SIEGALL C PRESS OW
Citation: Ae. Frankel et al., ADVANCES IN IMMUNOTOXIN BIOLOGY AND THERAPY - A SUMMARY OF THE 4TH INTERNATIONAL-SYMPOSIUM ON IMMUNOTOXINS, Cancer research, 56(4), 1996, pp. 926-932
I-131 ANTI-CD45 ANTIBODY PLUS BUSULFAN CYCLOPHOSPHAMIDE IN MATCHED RELATED TRANSPLANTS FOR AML IN FIRST REMISSION/
Authors: MATTHEWS DC APPELBAUM FR EARY JF MITCHELL D PRESS OW BERNSTEIN ID
Citation: Dc. Matthews et al., I-131 ANTI-CD45 ANTIBODY PLUS BUSULFAN CYCLOPHOSPHAMIDE IN MATCHED RELATED TRANSPLANTS FOR AML IN FIRST REMISSION/, Blood, 88(10), 1996, pp. 556-556
PHASE-II TRIAL OF I-131 B1 (ANTI-CD20) ANTIBODY THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS
Authors: PRESS OW EARY JF APPELBAUM FR MARTIN PJ NELP WB GLENN S FISHER DR PORTER B MATTHEWS DC GOOLEY T BERNSTEIN ID
Citation: Ow. Press et al., PHASE-II TRIAL OF I-131 B1 (ANTI-CD20) ANTIBODY THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS, Lancet, 346(8971), 1995, pp. 336-340
CONSTITUTIVE ENDOCYTOSIS AND DEGRADATION OF CD22 BY HUMAN B-CELLS
Authors: SHAN DM PRESS OW
Citation: Dm. Shan et Ow. Press, CONSTITUTIVE ENDOCYTOSIS AND DEGRADATION OF CD22 BY HUMAN B-CELLS, The Journal of immunology, 154(9), 1995, pp. 4466-4475
TRANSLOCATION OF RICIN A-CHAIN INTO PROTEOLIPOSOMES RECONSTITUTED FROM GOLGI AND ENDOPLASMIC-RETICULUM
Authors: BILGE A WARNER CV PRESS OW
Citation: A. Bilge et al., TRANSLOCATION OF RICIN A-CHAIN INTO PROTEOLIPOSOMES RECONSTITUTED FROM GOLGI AND ENDOPLASMIC-RETICULUM, The Journal of biological chemistry, 270(40), 1995, pp. 23720-23725
DEVELOPMENT OF A MARROW TRANSPLANT REGIMEN FOR ACUTE-LEUKEMIA USING TARGETED HEMATOPOIETIC IRRADIATION DELIVERED BY I-131-LABELED ANTI-CD45ANTIBODY, COMBINED WITH CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION
Authors: MATTHEWS DC APPELBAUM FR EARY JF FISHER DR DURACK LD BUSH SA HUI TE MARTIN PJ MITCHELL D PRESS OW BADGER CC STORB R NELP WB BERNSTEIN ID
Citation: Dc. Matthews et al., DEVELOPMENT OF A MARROW TRANSPLANT REGIMEN FOR ACUTE-LEUKEMIA USING TARGETED HEMATOPOIETIC IRRADIATION DELIVERED BY I-131-LABELED ANTI-CD45ANTIBODY, COMBINED WITH CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION, Blood, 85(4), 1995, pp. 1122-1131
TRANSLOCATION OF RICIN A-CHAIN (RTA) INTO VESICLES RECONSTITUTED FROMPURIFIED GOLGI AND ENDOPLASMIC-RETICULUM (ER)
Authors: BILGE A PRESS OW
Citation: A. Bilge et Ow. Press, TRANSLOCATION OF RICIN A-CHAIN (RTA) INTO VESICLES RECONSTITUTED FROMPURIFIED GOLGI AND ENDOPLASMIC-RETICULUM (ER), The FASEB journal, 8(4), 1994, pp. 10000504-10000504
POST THERAPY IMAGING IN HIGH-DOSE I-131 RADIOIMMUNOTHERAPY PATIENTS
Authors: EARY JF POLLARD KR DURACK LD BICE AN LEWELLEN TK MATTHEWS D PRESS OW NELP WB APPELBAUM FR BERNSTEIN I
Citation: Jf. Eary et al., POST THERAPY IMAGING IN HIGH-DOSE I-131 RADIOIMMUNOTHERAPY PATIENTS, Medical physics, 21(7), 1994, pp. 1157-1162
DEVELOPMENT OF A MARROW TRANSPLANT REGIMEN FOR ACUTE-LEUKEMIA USING TARGETED HEMATOPOIETIC IRRADIATION DELIVERED BY I-131-LABELED ANTI-CD45ANTIBODY, COMBINED WITH CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION
Authors: MATTHEWS DC APPELBAUM FR EARY JF FISHER DR MARTIN PJ PRESS OW BERNSTEIN LD
Citation: Dc. Matthews et al., DEVELOPMENT OF A MARROW TRANSPLANT REGIMEN FOR ACUTE-LEUKEMIA USING TARGETED HEMATOPOIETIC IRRADIATION DELIVERED BY I-131-LABELED ANTI-CD45ANTIBODY, COMBINED WITH CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION, Blood, 84(10), 1994, pp. 10000252-10000252
Risultati: 1-25 | 26-31